India Preclinical Imaging Market: Will 2026 Be the Year of Domestic R&D Sovereignty? As of January 2026, the India preclinical imaging market is identifying as a strategic cornerstone of the nation's "Make in India" pharmaceutical push, with the sector projected to surpass a valuation of $210 million this year. The 2026 landscape is defined by the full-scale operationalization of the Anusandhan National Research Foundation (ANRF), which has initiated a specialized ₹750 crore...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Portuguese
Italiano
Portuguese (Brazil)
china